NovaBay Pharma (NBY) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $1.76 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- UBS Downgrades H.U. Group Holdings Inc (4544:JP) to Neutral
- Paycom Software (PAYC) PT Raised to $285 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
